Compare Snap On Incorporated (SNA) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Snap On Incorporated vs Zoetis Inc — how do they compare? Snap On Incorporated trades at $360.37 (market cap $18.56B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is the larger of the two by market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold Snap On Incorporated for 37 Days and Zoetis Inc for 70 Days on average.
| SNA | ZTS | |
|---|---|---|
Market Cap | $18.56B | $30.20B |
Volume | 401,326 | 6,175,327 |
Sector | Industrials | Health |
52-Week High | $419.31 | $147.53 |
52-Week Low | $327.33 | $69.09 |
Typical Hold Time | 37 Days | 70 Days |
Enterprise Value | $18.20B | $37.76B |
Dividend Yield | 2.72% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Snap-On Incorporated (SNA) trades at $358.88, down 0.28% on the day, with a bearish technical signal from moving averages and oscillators. The company reported solid fundamentals with a 19.6% net income margin and a 17.58% ROE for 2025. Recent earnings show a mix of beats and a miss, with Q3 2026 results pending. Analyst consensus is bullish with a $449 price target, but technical indicators suggest near-term caution amid institutional position adjustments.
The outlook for SNA is supported by strong profitability and analyst optimism, but faces headwinds from technical bearishness and valuation risks. Investment opportunity lies in execution of RCI initiatives and diagnostic segment growth, while risks include integration costs from acquisitions and softer OEM demand. The stock's premium valuation requires sustained earnings growth to justify further upside.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
